IP Library › Patent Application 16805056
Patent Application
App. No. 16/805,056

RIFAXIMIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/805,056
Abstract

Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa.

Claims (6)

1 .- 22 . (canceled)

23 . A pharmaceutical composition comprising amorphous rifaximin, silicon dioxide, disodium edetate, hydroxypropyl methyl cellulose, microcrystalline cellulose, sodium starch glycolate, and glycerol palmitostearate.

24 . The pharmaceutical composition of claim 23 , wherein the amorphous rifaximin is characterized by the XRPD pattern shown in FIG. 1 .

25 . The pharmaceutical composition of claim 23 , wherein the pharmaceutical composition is in tablet form.

26 . A method of treating a bowel related disorder in a patient in need thereof, the method comprising administering a therapeutically effective amount of the pharmaceutical composition of claim 23 to the patient.

27 . The method of claim 26 , wherein the bowel related disorder is selected from the group consisting of irritable bowel syndrome, traveler's diarrhea, Crohn's disease, chronic pancreatitis, pancreatic insufficiency, and colitis.